Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis. [electronic resource]
Producer: 20130418Description: 104-12 p. digitalISSN:- 1878-5883
- Adolescent
- Adult
- Antibodies, Anti-Idiotypic -- biosynthesis
- Antibodies, Monoclonal, Humanized -- immunology
- Brain -- pathology
- Cell Migration Inhibition -- drug effects
- Disease-Free Survival
- Drug Resistance -- immunology
- Female
- Follow-Up Studies
- Humans
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Natalizumab
- Product Surveillance, Postmarketing
- Prognosis
- Prospective Studies
- Remission Induction
- Salvage Therapy
- Severity of Illness Index
- Transendothelial and Transepithelial Migration -- drug effects
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.